99 related articles for article (PubMed ID: 29504361)
1. Relationship between methylation status of RASSF2A gene promoter and endometriosis-associated ovarian cancer.
Xia Y; Xiong N; Huang Y
J Biol Regul Homeost Agents; 2018; 32(1):21-28. PubMed ID: 29504361
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
4. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Zhang Z; Sun D; Van do N; Tang A; Hu L; Huang G
Int J Cancer; 2007 Jan; 120(1):32-8. PubMed ID: 17013896
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.
Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y
J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823
[TBL] [Abstract][Full Text] [Related]
8. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis.
Ren F; Wang DB; Li T; Chen YH; Li Y
J Ovarian Res; 2014 Jul; 7():73. PubMed ID: 25298284
[TBL] [Abstract][Full Text] [Related]
10. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
[TBL] [Abstract][Full Text] [Related]
11. RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level.
Ren J; He W; Zhang R; Li Z; Cao W; Yao J; Zhu F; Zhang T; Wu G
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):309-12. PubMed ID: 19513612
[TBL] [Abstract][Full Text] [Related]
12. Promoter Methylation of RASSF1A Gene in Egyptian Patients with Ovarian Cancer.
Rezk NA; Mohamed RH; Alnemr AA; Harira M
Appl Biochem Biotechnol; 2018 May; 185(1):153-162. PubMed ID: 29098560
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of EZH2 reactivates RASSF2A by reversal of promoter methylation in breast cancer cells.
Yu P; Guo Y; Yusufu M; Liu Z; Wang S; Yin X; Peng G; Wang L; Zhao X; Guo H; Huang T; Liu C
Cell Biol Int; 2016 Oct; 40(10):1062-70. PubMed ID: 27436059
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis.
Ren F; Wang D; Jiang Y; Ren F
Arch Gynecol Obstet; 2012 Jan; 285(1):215-21. PubMed ID: 21556900
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of the IL-12B promotor region contributes to the risk of developing ovarian endometriosis.
Zhao W; Kang S; Zhao J; Wang L; Cao S; Li Y
Mol Reprod Dev; 2019 Jun; 86(6):632-638. PubMed ID: 30865360
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
[TBL] [Abstract][Full Text] [Related]
17. Correlations between gastric cancer family history and ROBO2 and RASSF2A gene methylations.
Chang ZW; Dong L; Qin YR; Song M; Guo HY; Zhu QL
J Cancer Res Ther; 2016; 12(2):597-600. PubMed ID: 27461616
[TBL] [Abstract][Full Text] [Related]
18. [Vincristine inhibits the proliferation of ovarian cancer cells by regulating the demethylation of RASSF2A].
Wang WX; Fan WW; Gao YX; Dong XC; Feng XJ; Ren J
Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):932-938. PubMed ID: 34530575
[No Abstract] [Full Text] [Related]
19. Expression and significance of ARID1A mRNA in endometriosis- associated ovarian cancer.
Wang Q; Wang L; L Y; Ding X; Liu A
J BUON; 2017; 22(5):1314-1321. PubMed ID: 29135119
[TBL] [Abstract][Full Text] [Related]
20. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.
Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F
Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
